Moderna, Inc.
Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| MRNA.MX | 261780.KQ | 068270.KS | BAVA.CO | NVAX | VIR | |
|---|---|---|---|---|---|---|
| Market cap | 1.86T | 107.79B | 45.06T | 18.30B | 1.82B | 1.79B |
| P/E (TTM) | — | — | — | 12.5 | — | — |
| Forward P/E | — | — | — | 22.4 | -67.2 | -4.2 |
| Price/book | 14.9 | — | — | 1.4 | -9.5 | 1.8 |
| Dividend yield | — | — | 0.36% | — | — | — |
| 1-year change | +814.29% | +44.26% | +16.25% | +0.08% | +35.11% | +75.49% |
| Today | +3.80% | +4.57% | +0.10% | +0.74% | −3.67% | −1.58% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All MRNA.MX news ›Should You Sell Your Moderna Stock Now?
Little Of Moderna’s Price Comes From Today’s Sales Very little. Moderna stock trades at 40.9 times its sales over the past twelve months, compared with 3.1 times for the S&P 500. A price-to-earnings ratio is not meaningful for Moderna, as…
Moderna Just Joined the Nasdaq-100. Here's What That Means for Investors.
The recent meteoric rally of MRNA shares has made Moderna a massive company. Its market cap has grown so large, in fact, that it’s earned a place among Nasdaq’s largest listings. Regardless of its size, investors should remain focused on a…
Merck and Moderna Prepare FDA Filing for Personalized mRNA Melanoma Vaccine Paired with Keytruda After Phase 3 Results
Merck and Moderna Prepare FDA Filing for Personalized… inkl Merck and Moderna Prepare FDA Filing for Personalized mRNA Melanoma Vaccine Paired with Keytruda After Phase 3 Results Merck and Moderna are preparing to file their personalized…
Merck/Moderna, Summit/Akeso and ADCs to headline ESMO 2026
Antibody-drug conjugates, a groundbreaking cancer vaccine under development by Merck and Moderna and a closely watched PD-1xVEGF bispecific therapy from Summit Therapeutics and Akeso will be top of mind when the world’s foremost oncology…
Moderna’s Friday Slide Says More About Positioning Than About Science
Moderna’s 8.0% drop on Friday should be read as a warning against inflated expectations, not as evidence of an operational setback. According to media reports, the stock came under pressure in a broader selloff of biotechnology and other…
Stocktwits Pharma Pulse: Moderna-Merck Cancer Vaccine Grabs Spotlight As Kidney-Cancer And MS Data Pour In
The biotech spotlight will move from kidney cancer to Huntington’s disease and personalized cancer treatment this week, as Arcus Biosciences (RCUS), Alnylam (ALNY), Moderna (MRNA) and Merck (MRK) deliver clinical updates amid a busy…
Move Aside, Moderna: This mRNA Stock Is Sitting on a Cash Pile and a Deep Cancer Pipeline
A 16.6 billion euro cash balance gives BioNTech room to fund trials, partnerships, and a $1 billion share repurchase program. With 14 pivotal trials underway, including seven for pumitamig, BioNTech’s oncology pipeline is moving well…
Moderna retreats 8% amid valuation debate ahead of cancer data
(MRNA:NASDAQ) Seeking Alpha SA Spotlight uses AI to summarize content published on Seeking Alpha. All summaries are reviewed by human editors prior to publication. Shares of Moderna (MRNA), an mRNA medicines developer, sank almost 8% on…
Moderna (NASDAQ:MRNA) Stock: Insider Stephen Hoge Sells 39,145 Shares
Posted by Defense World Staff on Oct 18th, 2026 Stephen Hoge also recently made the following trade(s): Read Our Latest Research Report on Moderna Here are the key news stories impacting Moderna this week: Moderna, Inc is a biotechnology…
Novavax Plunges 12% as Selloff Hits Vaccine Makers; Moderna Tumbles 10%, Pfizer Holds Steady
Vaccine stocks are cracking under intense selling pressure, and one small developer with no control over its own commercial fate is bearing the worst of it. Whether its big-pharma partner can change that story is the question every…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
tradingview.com32
-
marketscreener.com27
-
seekingalpha.com18
-
stocktitan.net17
-
gurufocus.com15
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.